Talquetamab–Daratumumab in Relapsed or Refractory Myeloma

Roberto Mina

Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy

Meral Beksac

Paula Rodriguez-Otero

Wenming Chen

Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing

María-Victoria Mateos

Jian Li

Philippe Moreau

Yael C. Cohen

Tel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel

Chang-Ki Min

Seoul St. Mary’s Hospital, Catholic University of Korea, Seoul, South Korea

Tomas Jelinek

Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic

Jing Christine Ye

M.D. Anderson Cancer Center, University of Texas, Houston

Hila Magen

Chaim Sheba Medical Center, Ramat-Gan, Israel

Samuel M. Rubinstein

Division of Hematology and Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill

Weijun Fu

Department of Hematology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai

Vania Hungria

Clinica São Germano, São Paulo

Guldane Cengiz Seval

Joao Samuel Farias

Liga Paranaense de Combate ao Câncer, Curitiba, Paraná, Brazil

Jakub Radocha

4th Department of Internal Medicine–Hematology, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic

Senem Maral

Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey

Mehmet Turgut

Ondokuz Mayıs University, Samsun, Turkey

Youngil Koh

Seoul National University Hospital, Seoul National University, Jongno-gu, Seoul, South Korea

Daniel O’Leary

Booth School of Business

Jayr Schmidt Filho

Department of Hematology, A.C. Camargo Cancer Center, São Paulo

Raymond Thertulien

Novant Heath, Charlotte, NC

Gang An

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Shang-Yi Huang

Department of Internal Medicine, National Taiwan University Hospital

Sebastian Grosicki

Department of Cancer Prevention, Medical University of Silesia, Katowice, Poland

Agata Tyczyńska

Medical University of Gdańsk, Department of Hematology and Transplantology and University Clinical Center Gdańsk, Department of Hematology, Transplantology and Cellular Therapies, Gdańsk, Poland

Rahul Banerjee

Matthew J. Pianko

University of Michigan Health, Ann Arbor

Joaquín Martínez-López

Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Complutense University of Madrid, Centro Nacional de Investigaciones Oncológicas, Madrid Institute of Cancer, Madrid

Pawel Steckiewicz

Holy Cross Cancer Center, Department of Hematology and Bone Marrow Transplantation, Kielce, Poland

Dai Maruyama

Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo

Kentaro Fukushima

University of Osaka Graduate School of Medicine, Suita, Japan

Albert Oriol

Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain

Jordi Lopez Pardo

l’Hospital de la Santa Creu i Sant Pau, Barcelona

Hartmut Goldschmidt

Internal Medicine V, Hematology, Oncology and Rheumatology, German-Speaking Myeloma Multicenter Group Study Group, Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, Germany

Charlotte Pawlyn

Aurore Perrot

Elena Zamagni

Meletios A. Dimopoulos

Leo Rasche

University Hospital of Würzburg, Würzburg, Germany

Jaszianne Tolbert

Johnson & Johnson, Spring House, PA

William Terry

Johnson & Johnson, Spring House, PA

Christelle Courtoux

Johnson & Johnson, Spring House, PA

Xiao Liu

Sandra Y. Vasey

Johnson & Johnson, Spring House, PA

Kaitlyn Connors

Johnson & Johnson, Raritan, NJ

Mariacristina Festa

Johnson & Johnson, Leiden, the Netherlands

Christoph Heuck

Johnson & Johnson, Spring House, PA

Angélique Langlois

Johnson & Johnson, Spring House, PA

Lisa O’Rourke

Johnson & Johnson, Spring House, PA

Jiangxiu Zhou

Johnson & Johnson, Spring House, PA

Xiang Qin

Johnson & Johnson, Spring House, PA

Jiashen Lu

Johnson & Johnson, Shanghai

Joy Gong

Johnson & Johnson, Spring House, PA

Diego Vieyra

Johnson & Johnson, Spring House, PA

Peter M. Voorhees

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC